ADVISORY, Sept. 25, 2013 (GLOBE NEWSWIRE) -- What: Ophthotech Corp. [OPHT], a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the eye, will visit the NASDAQ MarketSite in Times Square in celebration of its September 25 initial public offering (IPO) on The NASDAQ Stock Market.
Help employers find you! Check out all the jobs and post your resume.
